Serotype specific primers and gel-based RT-PCR assays for 'typing' African horse sickness virus: identification of strains from Africa.
African horse sickness is a devastating, transboundary animal disease, that is 'listed' by the Office International des Epizooties (OIE). Although attenuated, inactivated and subunit vaccines have been developed for African horse sickness virus (AHSV), these are serotype-specific and their effective deployment therefore relies on rapid and reliable identification of virus type. AHSV serotype is controlled by the specificity of interactions between neutralising antibodies, and components of the outer-capsid, particularly protein VP2 (encoded by AHSV genome segment 2 (Seg-2)). We report the development and evaluation of novel gel based reverse transcription-PCR (RT-PCR) assays targeting AHSV Seg-2, which can be used to very significantly increase the speed and reliability of detection and identification (compared to virus neutralisation tests) of the nine serotypes of AHSV. Primer sets were designed targeting regions of Seg-2 that are conserved between strains within each of the AHSV serotype (types 1 to 9). These assays were evaluated using multiple AHSV strains from the orbivirus reference collection at IAH (www.reoviridae.org/dsRNA_virus_proteins/ReoID/AHSV-isolates.htm). In each case the Seg-2 primers showed a high level of specificity and failed to cross-amplify the most closely related heterologous AHSV types, or other related orbiviruses (such as bluetongue virus (BTV), or equine encephalosis virus (EEV)). The assays are rapid and sensitive, and can be used to detect and type viral RNA in blood, tissue samples, or cultivated viral suspensions within 24 h. They were used to identify AHSV strains from recent outbreaks in sub-Saharan African countries. These methods also generate cDNAs suitable for sequencing and phylogenetic analyses of Seg-2, identifying distinct virus lineages within each virus-type and helping to identify strain movements/origins. The RT-PCR methods described here provide a robust and versatile tool for rapid and specific detection and identification of AHSV serotypes 1 to 9.
Vector-borne Disease Programme, Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey, United Kingdom.
Narender S
NS
Maan
Sushila
S
Maan
Kyriaki
K
Nomikou
Manjunatha N
MN
Belaganahalli
Katarzyna
K
Bachanek-Bankowska
Peter P C
PP
Mertens
D000349:Africa; D000818:Animals; D002460:Cell Line; D019295:Computational Biology / Q000379:methods*; D017931:DNA Primers / Q000235:genetics*; D005782:Gels; D006736:Horses; D007106:Immune Sera / Q000276:immunology; D018163:Orbivirus / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification*; D012367:RNA, Viral / Q000235:genetics / Q000302:isolation & purification; D012015:Reference Standards; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods*; D012703:Serotyping / Q000379:methods* / Q000592:standards; D013045:Species Specificity; D014764:Viral Proteins / Q000235:genetics; D014765:Viral Vaccines / Q000276:immunology
D017931:DNA Primers; D005782:Gels; D007106:Immune Sera; D012367:RNA, Viral; D014764:Viral Proteins; D014765:Viral Vaccines